Nifty

:

23346.40

Sensex

:

74294.96

75.80 (0.33%)
-19.63 (-0.03%)

Login

Nifty
Sensex

:
:

23346.40
74294.96

75.80 (0.33%)
-19.63 (-0.03%)

Hikal Ltd.

Pharmaceuticals & Drugs - Global

Rating :

48/99

BSE: 524735 | NSE: HIKAL

Watchlist

NSE BSE

226.04

18-Sep-2026

Open
High
Low
Previous Close

225.29
232.34
224.6
225.29

Volume
Traded Value (lacs)
52 Week High
52 Week Low

382596
87376608.33
282.7
146.25

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,787.83
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,454.63
0.27%
2.34

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.38
-2.49
-1.36

EBITDA CAGR (%)

10 Years
5 Years
3 Years

1.05
-8.33
-3.76

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

35.45
47.17
50.44

P:BV (Average)

8 Years
5 Years
3 Years

3.29
3.51
3.02

EV:EBITDA (Average)

8 Years
5 Years
3 Years

13.95
16.05
15.69

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 402.80 380.40 5.89% 519.40 552.40 -5.97% 494.30 447.70 10.41% 318.50 452.90 -29.68%
Expenses 365.90 355.60 2.90% 413.80 428.90 -3.52% 411.60 375.50 9.61% 311.10 378.20 -17.74%
EBITDA 36.90 24.80 48.79% 105.60 123.50 -14.49% 82.70 72.20 14.54% 7.40 74.70 -90.09%
EBIDTM 9.16% 6.52% 20.33% 22.36% 16.73% 16.13% 2.32% 16.49%
Other Income 1.80 1.00 80.00% 6.60 0.50 1,220.00% 2.80 3.60 -22.22% 1.90 0.40 375.00%
Interest 14.90 17.10 -12.87% 14.60 17.90 -18.44% 15.50 18.70 -17.11% 14.90 18.80 -20.74%
Depreciation 42.70 39.40 8.38% 42.00 37.70 11.41% 41.20 33.20 24.10% 41.20 31.70 29.97%
PBT -10.00 -30.70 - 8.50 68.40 -87.57% -9.20 23.90 - -46.80 24.60 -
Tax -2.50 -8.00 - -6.10 18.10 - -3.30 6.60 - -12.10 6.50 -
PAT -7.50 -22.70 - 14.60 50.30 -70.97% -5.90 17.30 - -34.70 18.10 -
PATM -1.86% -5.97% 2.81% 9.11% -1.19% 3.86% -10.89% 4.00%
EPS -0.61 -1.84 - 1.18 4.08 -71.08% -0.48 1.40 - -2.81 1.47 -

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 402.80 380.40 5.89% 519.40 552.40 -5.97% 494.30 447.70 10.41% 318.50 452.90 -29.68%
Expenses 365.80 355.30 2.96% 414.00 429.00 -3.50% 411.60 375.60 9.58% 311.30 378.00 -17.65%
EBITDA 37.00 25.10 47.41% 105.40 123.40 -14.59% 82.70 72.10 14.70% 7.20 74.90 -90.39%
EBIDTM 9.19% 6.60% 20.29% 22.34% 16.73% 16.10% 2.26% 16.54%
Other Income 1.80 1.00 80.00% 6.60 0.50 1,220.00% 2.80 3.60 -22.22% 1.90 0.40 375.00%
Interest 14.90 17.10 -12.87% 14.60 17.90 -18.44% 15.50 18.70 -17.11% 14.90 18.80 -20.74%
Depreciation 42.70 39.40 8.38% 42.00 37.70 11.41% 41.20 33.20 24.10% 41.20 31.70 29.97%
PBT -9.90 -30.40 - 8.30 68.30 -87.85% -9.20 23.80 - -47.00 24.80 -
Tax -2.50 -8.00 - -6.10 18.10 - -3.30 6.60 - -12.10 6.50 -
PAT -7.40 -22.40 - 14.40 50.20 -71.31% -5.90 17.20 - -34.90 18.30 -
PATM -1.84% -5.89% 2.77% 9.09% -1.19% 3.84% -10.96% 4.04%
EPS -0.60 -1.81 - 1.17 4.06 -71.18% -0.48 1.39 - -2.83 1.48 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 1,735.00 1,712.60 1,859.80 1,784.60 2,023.03 1,942.72 1,720.44 1,507.26 1,589.61 1,296.09 1,013.94 Net Sales Growth -5.37% -7.91% 4.21% -11.79% 4.13% 12.92% 14.14% -5.18% 22.65% 27.83% Cost Of Goods Sold 757.50 761.70 837.30 824.70 1,107.03 996.39 908.37 776.32 853.82 698.90 508.88 Gross Profit 977.50 950.90 1,022.50 959.90 916.00 946.33 812.06 730.94 735.79 597.19 505.06 GP Margin 56.34% 55.52% 54.98% 53.79% 45.28% 48.71% 47.20% 48.49% 46.29% 46.08% 49.81% Total Expenditure 1,502.40 1,492.10 1,531.30 1,517.70 1,765.97 1,602.15 1,397.55 1,234.10 1,291.48 1,054.35 816.74 Power & Fuel Cost - 169.80 168.10 170.20 186.91 175.46 147.83 129.99 132.04 108.41 85.63 % Of Sales - 9.91% 9.04% 9.54% 9.24% 9.03% 8.59% 8.62% 8.31% 8.36% 8.45% Employee Cost - 266.00 242.30 244.00 220.40 201.35 164.32 156.57 135.69 128.06 116.69 % Of Sales - 15.53% 13.03% 13.67% 10.89% 10.36% 9.55% 10.39% 8.54% 9.88% 11.51% Manufacturing Exp. - 132.40 141.30 133.70 111.43 104.05 85.18 85.78 83.61 50.48 38.41 % Of Sales - 7.73% 7.60% 7.49% 5.51% 5.36% 4.95% 5.69% 5.26% 3.89% 3.79% General & Admin Exp. - 80.60 69.50 85.70 79.15 60.89 38.67 43.05 35.77 28.33 30.77 % Of Sales - 4.71% 3.74% 4.80% 3.91% 3.13% 2.25% 2.86% 2.25% 2.19% 3.03% Selling & Distn. Exp. - 49.40 45.90 33.30 34.03 42.74 31.46 20.45 23.36 22.52 18.02 % Of Sales - 2.88% 2.47% 1.87% 1.68% 2.20% 1.83% 1.36% 1.47% 1.74% 1.78% Miscellaneous Exp. - 32.20 26.90 26.10 27.02 21.28 21.71 21.95 27.19 17.66 18.02 % Of Sales - 1.88% 1.45% 1.46% 1.34% 1.10% 1.26% 1.46% 1.71% 1.36% 1.81% EBITDA 232.60 220.50 328.50 266.90 257.06 340.57 322.89 273.16 298.13 241.74 197.20 EBITDA Margin 13.41% 12.88% 17.66% 14.96% 12.71% 17.53% 18.77% 18.12% 18.75% 18.65% 19.45% Other Income 13.10 12.30 5.00 2.50 5.41 4.89 4.98 3.70 2.26 4.46 3.44 Interest 59.90 62.10 75.20 56.40 48.10 31.22 36.20 52.42 58.43 49.12 48.27 Depreciation 167.10 163.80 134.40 117.60 109.01 95.67 85.25 82.46 92.88 85.59 69.14 PBT -57.50 6.90 123.90 95.40 105.36 218.57 206.43 141.98 149.09 111.49 83.22 Tax -24.00 -29.50 33.00 25.90 26.98 58.06 73.28 42.14 46.01 34.27 12.55 Tax Rate 41.74% 37.72% 26.63% 27.15% 25.61% 26.56% 35.50% 33.29% 30.86% 30.74% 15.08% PAT -33.50 -48.70 90.90 69.50 78.38 160.51 133.14 84.44 103.08 77.23 70.67 PAT before Minority Interest -33.50 -48.70 90.90 69.50 78.38 160.51 133.14 84.44 103.08 77.23 70.67 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -1.93% -2.84% 4.89% 3.89% 3.87% 8.26% 7.74% 5.60% 6.48% 5.96% 6.97% PAT Growth -153.17% - 30.79% -11.33% -51.17% 20.56% 57.67% -18.08% 33.47% 9.28% EPS -2.72 -3.95 7.37 5.64 6.36 13.02 10.80 6.85 8.36 6.26 5.73

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 1,735.00 1,712.60 1,859.80 1,784.60 2,023.03 1,942.72 1,720.44 1,507.26 1,589.61 1,296.09 1,013.94 Net Sales Growth -5.37% -7.91% 4.21% -11.79% 4.13% 12.92% 14.14% -5.18% 22.65% 27.83% Cost Of Goods Sold 757.50 761.70 837.30 824.70 1,107.03 996.39 908.37 776.32 853.82 698.90 508.88 Gross Profit 977.50 950.90 1,022.50 959.90 916.00 946.33 812.06 730.94 735.79 597.19 505.06 GP Margin 56.34% 55.52% 54.98% 53.79% 45.28% 48.71% 47.20% 48.49% 46.29% 46.08% 49.81% Total Expenditure 1,502.70 1,492.20 1,531.40 1,517.60 1,765.96 1,602.16 1,397.55 1,234.11 1,291.48 1,054.35 815.48 Power & Fuel Cost - 169.80 168.10 170.20 186.91 175.46 147.83 129.99 132.04 108.41 85.63 % Of Sales - 9.91% 9.04% 9.54% 9.24% 9.03% 8.59% 8.62% 8.31% 8.36% 8.45% Employee Cost - 270.30 247.10 246.50 222.44 203.38 164.32 156.57 135.69 128.06 116.69 % Of Sales - 15.78% 13.29% 13.81% 11.00% 10.47% 9.55% 10.39% 8.54% 9.88% 11.51% Manufacturing Exp. - 132.40 141.30 133.70 111.43 104.05 85.18 85.78 83.61 50.48 38.41 % Of Sales - 7.73% 7.60% 7.49% 5.51% 5.36% 4.95% 5.69% 5.26% 3.89% 3.79% General & Admin Exp. - 88.20 72.30 86.90 80.23 60.89 38.68 43.05 35.77 28.33 30.77 % Of Sales - 5.15% 3.89% 4.87% 3.97% 3.13% 2.25% 2.86% 2.25% 2.19% 3.03% Selling & Distn. Exp. - 37.60 38.40 29.60 30.89 40.71 31.46 20.45 23.36 22.52 18.02 % Of Sales - 2.20% 2.06% 1.66% 1.53% 2.10% 1.83% 1.36% 1.47% 1.74% 1.78% Miscellaneous Exp. - 32.20 26.90 26.00 27.03 21.29 21.71 21.95 27.19 17.66 18.02 % Of Sales - 1.88% 1.45% 1.46% 1.34% 1.10% 1.26% 1.46% 1.71% 1.36% 1.69% EBITDA 232.30 220.40 328.40 267.00 257.07 340.56 322.89 273.15 298.13 241.74 198.46 EBITDA Margin 13.39% 12.87% 17.66% 14.96% 12.71% 17.53% 18.77% 18.12% 18.75% 18.65% 19.57% Other Income 13.10 12.30 5.00 2.50 5.41 4.89 4.98 3.70 2.26 4.46 3.44 Interest 59.90 62.10 75.20 56.40 48.10 31.22 36.20 52.42 58.43 49.12 48.27 Depreciation 167.10 163.80 134.40 117.60 109.01 95.67 85.25 82.46 92.88 85.59 69.14 PBT -57.80 6.80 123.80 95.50 105.37 218.56 206.43 141.98 149.08 111.49 84.47 Tax -24.00 -29.50 33.00 25.90 26.98 58.06 73.28 42.14 46.01 34.27 12.55 Tax Rate 41.52% 37.68% 26.66% 27.12% 25.61% 26.56% 35.50% 33.29% 30.86% 30.74% 15.64% PAT -33.80 -48.80 90.80 69.60 78.38 160.50 133.14 84.44 103.08 77.23 67.72 PAT before Minority Interest -33.80 -48.80 90.80 69.60 78.38 160.50 133.14 84.44 103.08 77.23 67.72 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -1.95% -2.85% 4.88% 3.90% 3.87% 8.26% 7.74% 5.60% 6.48% 5.96% 6.68% PAT Growth -153.40% - 30.46% -11.20% -51.17% 20.55% 57.67% -18.08% 33.47% 14.04% EPS -2.74 -3.96 7.36 5.64 6.36 13.02 10.80 6.85 8.36 6.26 5.49

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,199.00 1,262.20 1,187.60 1,133.49 1,068.01 933.42 816.52 756.22 669.39 604.99 Share Capital 24.70 24.70 24.70 24.66 24.66 24.66 24.66 24.66 16.44 16.44 Total Reserves 1,174.30 1,237.50 1,162.90 1,108.83 1,043.35 908.76 791.86 731.56 652.96 588.55 Non-Current Liabilities 487.70 533.10 643.00 590.46 431.90 378.99 410.16 359.42 311.82 324.23 Secured Loans 373.10 367.20 422.90 489.88 286.68 262.89 303.40 297.84 296.63 320.15 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 55.70 71.70 128.20 24.22 79.59 77.94 73.43 48.74 15.65 14.30 Current Liabilities 678.70 1,011.10 932.80 661.53 828.13 703.30 652.77 659.02 616.17 470.29 Trade Payables 266.30 304.20 278.80 313.24 249.05 229.61 201.16 160.00 164.55 130.43 Other Current Liabilities 193.30 192.30 172.80 157.49 232.09 148.61 133.28 136.11 113.94 75.93 Short Term Borrowings 178.50 263.30 288.60 173.31 272.60 251.43 257.54 301.88 277.16 230.24 Short Term Provisions 40.60 251.30 192.60 17.49 74.39 73.65 60.80 61.03 60.52 33.69 Total Liabilities 2,365.40 2,806.40 2,763.40 2,385.48 2,328.04 2,015.71 1,879.45 1,774.66 1,597.38 1,399.51 Net Block 1,332.90 1,364.50 1,070.60 948.31 879.46 712.55 735.22 712.96 633.59 668.33 Gross Block 2,404.20 2,225.20 1,802.40 1,563.59 1,387.80 1,127.49 1,064.92 960.28 788.33 737.47 Accumulated Depreciation 1,024.20 860.70 731.80 615.27 508.33 414.94 329.70 247.31 154.73 69.14 Non Current Assets 1,481.30 1,588.20 1,620.70 1,446.47 1,304.79 1,090.59 1,048.23 888.18 851.30 792.72 Capital Work in Progress 94.50 121.20 414.30 412.15 294.78 254.24 160.82 78.69 117.88 62.76 Non Current Investment 9.50 9.50 5.40 5.31 0.65 0.62 0.69 1.03 2.61 3.63 Long Term Loans & Adv. 43.50 91.20 129.40 75.91 128.77 117.82 148.35 89.19 95.58 52.06 Other Non Current Assets 0.90 1.80 1.00 4.78 1.13 5.36 3.15 6.31 1.64 5.95 Current Assets 884.10 1,218.20 1,142.70 939.00 1,023.25 925.12 831.22 886.48 746.08 606.79 Current Investments 0.00 0.00 0.00 0.00 10.27 0.00 0.00 0.00 0.00 0.00 Inventories 358.10 334.50 303.70 316.74 328.98 266.70 312.46 364.23 303.05 263.58 Sundry Debtors 441.60 522.40 550.30 441.78 437.72 485.53 340.44 349.72 287.37 256.47 Cash & Bank 13.80 17.90 20.80 59.53 49.09 36.81 63.57 31.74 27.22 16.46 Other Current Assets 70.60 16.90 19.90 17.93 197.19 136.08 114.74 140.78 128.42 70.28 Short Term Loans & Adv. 59.00 326.50 248.00 103.01 174.12 124.17 106.80 136.65 123.67 66.39 Net Current Assets 205.40 207.10 209.90 277.48 195.11 221.82 178.45 227.46 129.91 136.51 Total Assets 2,365.40 2,806.40 2,763.40 2,385.47 2,328.04 2,015.71 1,879.45 1,774.66 1,597.38 1,399.51

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,198.80 1,262.30 1,187.70 1,133.47 1,067.98 933.40 816.50 756.21 669.38 604.98 Share Capital 24.70 24.70 24.70 24.66 24.66 24.66 24.66 24.66 16.44 16.44 Total Reserves 1,174.10 1,237.60 1,163.00 1,108.81 1,043.32 908.74 791.84 731.55 652.95 588.54 Non-Current Liabilities 487.70 533.10 643.00 590.46 431.90 378.99 410.16 359.42 311.82 324.23 Secured Loans 373.10 367.20 422.90 489.88 286.68 262.89 303.40 297.84 296.63 320.15 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 55.70 71.70 128.20 24.22 79.59 77.94 73.43 48.74 15.65 14.30 Current Liabilities 678.90 1,010.80 932.80 661.55 828.15 703.31 652.77 659.02 616.17 470.29 Trade Payables 266.50 304.10 278.80 313.27 249.07 229.62 201.16 160.01 164.55 130.43 Other Current Liabilities 193.30 192.10 172.80 157.49 232.09 148.61 133.28 136.11 113.94 75.93 Short Term Borrowings 178.50 263.30 288.60 173.31 272.60 251.43 257.54 301.88 277.16 230.24 Short Term Provisions 40.60 251.30 192.60 17.49 74.39 73.65 60.80 61.03 60.52 33.69 Total Liabilities 2,365.40 2,806.20 2,763.50 2,385.48 2,328.03 2,015.70 1,879.43 1,774.65 1,597.37 1,399.50 Net Block 1,332.90 1,364.50 1,070.60 948.31 879.46 712.55 735.22 712.96 633.59 668.33 Gross Block 2,404.20 2,225.20 1,802.40 1,563.59 1,387.80 1,127.49 1,064.92 960.28 788.33 737.47 Accumulated Depreciation 1,024.20 860.70 731.80 615.27 508.33 414.94 329.70 247.31 154.73 69.14 Non Current Assets 1,481.30 1,589.50 1,620.70 1,446.46 1,304.78 1,090.58 1,048.22 888.17 851.29 792.71 Capital Work in Progress 94.50 121.20 414.30 412.15 294.78 254.24 160.82 78.69 117.88 62.76 Non Current Investment 9.50 9.50 5.40 5.30 0.64 0.61 0.68 1.02 2.60 3.62 Long Term Loans & Adv. 43.50 92.50 129.40 75.91 128.77 117.82 148.35 89.19 95.58 52.06 Other Non Current Assets 0.90 1.80 1.00 4.78 1.13 5.36 3.15 6.31 1.64 5.95 Current Assets 884.10 1,216.70 1,142.80 939.02 1,023.25 925.12 831.22 886.48 746.08 606.79 Current Investments 0.00 0.00 0.00 0.00 10.27 0.00 0.00 0.00 0.00 0.00 Inventories 358.10 334.50 303.70 316.74 328.98 266.70 312.46 364.23 303.05 263.58 Sundry Debtors 441.60 522.40 550.30 441.78 437.72 485.53 340.44 349.72 287.37 256.47 Cash & Bank 13.80 18.00 20.90 59.55 49.09 36.81 63.57 31.74 27.22 16.46 Other Current Assets 70.60 16.90 19.90 17.93 197.19 136.08 114.74 140.78 128.42 70.28 Short Term Loans & Adv. 59.00 324.90 248.00 103.01 174.12 124.17 106.80 136.65 123.67 66.39 Net Current Assets 205.20 205.90 210.00 277.47 195.10 221.81 178.44 227.45 129.91 136.51 Total Assets 2,365.40 2,806.20 2,763.50 2,385.48 2,328.03 2,015.70 1,879.44 1,774.65 1,597.37 1,399.50

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 302.10 280.40 186.60 315.29 293.73 229.02 284.93 185.59 138.81 163.49 PBT -78.20 123.90 95.40 105.36 218.57 206.43 141.98 149.09 111.49 83.22 Adjustment 277.80 215.10 174.90 163.13 126.27 126.99 136.17 158.81 140.35 123.92 Changes in Working Capital 116.90 -28.80 -53.40 75.60 18.69 -57.90 46.49 -89.69 -87.16 -23.92 Cash after chg. in Working capital 316.50 310.20 216.90 344.09 363.53 275.52 324.64 218.21 164.69 183.22 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.40 -29.80 -30.30 -28.80 -69.80 -46.50 -24.31 -32.62 -25.87 -19.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 -15.40 0.00 0.00 0.00 Cash From Investing Activity -145.30 -136.50 -173.70 -292.34 -284.37 -156.20 -163.80 -124.59 -110.12 -102.59 Net Fixed Assets -152.30 -129.70 -240.96 -293.16 -300.85 -155.99 -186.77 -132.76 -105.98 413.05 Net Investments 0.00 -4.10 -0.09 5.61 -10.30 0.07 0.34 1.58 1.02 -0.50 Others 7.00 -2.70 67.35 -4.79 26.78 -0.28 22.63 6.59 -5.16 -515.14 Cash from Financing Activity -160.10 -143.60 -27.00 -7.68 -5.56 -96.87 -100.86 -55.41 -24.79 -63.27 Net Cash Inflow / Outflow -3.30 0.30 -14.10 15.27 3.80 -24.05 20.27 5.59 3.90 -2.37 Opening Cash & Equivalents 12.90 12.60 26.70 11.44 7.64 31.68 11.41 5.82 1.93 4.29 Closing Cash & Equivalent 9.60 12.90 12.60 26.71 11.44 7.64 31.68 11.41 5.82 1.93

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 302.00 280.40 186.70 315.31 293.73 229.02 284.93 185.59 138.81 163.48 PBT -78.30 123.80 95.50 105.37 218.56 206.43 141.98 149.08 111.49 80.27 Adjustment 277.80 215.10 174.90 163.13 126.27 126.99 136.17 158.81 140.35 126.88 Changes in Working Capital 116.90 -28.70 -53.40 75.61 18.70 -57.89 46.49 -89.69 -87.16 -23.93 Cash after chg. in Working capital 316.40 310.20 217.00 344.11 363.53 275.52 324.64 218.21 164.69 183.22 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.40 -29.80 -30.30 -28.80 -69.80 -46.50 -24.31 -32.62 -25.87 -19.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 -15.40 0.00 0.00 0.00 Cash From Investing Activity -145.30 -136.50 -173.70 -292.34 -284.37 -156.20 -163.80 -124.59 -110.12 -102.17 Net Fixed Assets -152.30 -129.70 -240.96 -293.16 -300.85 -155.99 -186.77 -132.76 -105.98 413.05 Net Investments 0.00 -4.10 -0.09 5.61 -10.30 0.07 0.34 1.58 1.02 -0.50 Others 7.00 -2.70 67.35 -4.79 26.78 -0.28 22.63 6.59 -5.16 -514.72 Cash from Financing Activity -160.10 -143.60 -27.00 -7.68 -5.56 -96.87 -100.86 -55.40 -24.79 -63.28 Net Cash Inflow / Outflow -3.40 0.30 -14.00 15.29 3.80 -24.05 20.27 5.59 3.90 -1.96 Opening Cash & Equivalents 13.00 12.70 26.70 11.44 7.64 31.68 11.41 5.82 1.93 3.89 Closing Cash & Equivalent 9.60 13.00 12.70 26.73 11.44 7.64 31.68 11.41 5.82 1.93

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 97.08 102.20 96.16 91.93 86.62 75.70 66.22 61.33 54.29 49.07 ROA -1.88% 3.26% 2.70% 3.33% 7.39% 6.84% 4.62% 6.11% 5.15% 5.24% ROE -3.96% 7.42% 5.99% 7.12% 16.04% 15.22% 10.74% 14.46% 12.12% 13.28% ROCE -0.82% 9.89% 7.82% 8.47% 15.21% 16.15% 12.44% 15.25% 12.81% 12.14% Fixed Asset Turnover 0.74 0.92 1.06 1.37 1.54 1.57 1.49 1.82 1.70 1.10 Receivable days 102.73 105.26 101.45 79.34 86.73 87.62 83.56 73.14 76.34 65.09 Inventory Days 73.81 62.63 63.45 58.25 55.96 61.44 81.93 76.61 79.54 97.91 Payable days 136.69 127.07 131.01 92.70 87.67 86.55 52.18 44.26 48.94 56.68 Cash Conversion Cycle 39.84 40.82 33.89 44.89 55.02 62.51 113.32 105.49 106.94 106.32 Total Debt/Equity 0.57 0.60 0.69 0.66 0.63 0.65 0.79 0.87 0.95 0.99 Interest Cover -0.26 2.65 2.69 3.19 8.00 6.70 3.41 3.55 3.27 2.72

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 97.07 102.21 96.17 91.93 86.62 75.70 66.22 61.33 54.29 49.07 ROA -1.89% 3.26% 2.70% 3.33% 7.39% 6.84% 4.62% 6.11% 5.15% 5.02% ROE -3.97% 7.41% 6.00% 7.12% 16.04% 15.22% 10.74% 14.46% 12.12% 12.74% ROCE -0.83% 9.88% 7.82% 8.47% 15.21% 16.15% 12.44% 15.25% 12.81% 11.87% Fixed Asset Turnover 0.74 0.92 1.06 1.37 1.54 1.57 1.49 1.82 1.70 1.10 Receivable days 102.73 105.26 101.45 79.34 86.73 87.62 83.56 73.14 76.34 65.09 Inventory Days 73.81 62.63 63.45 58.25 55.96 61.44 81.93 76.61 79.54 97.91 Payable days 136.71 127.05 131.02 92.70 87.68 86.55 52.18 44.26 48.94 56.69 Cash Conversion Cycle 39.82 40.84 33.88 44.89 55.01 62.51 113.32 105.49 106.94 106.31 Total Debt/Equity 0.57 0.60 0.69 0.66 0.63 0.65 0.79 0.87 0.95 0.99 Interest Cover -0.26 2.65 2.69 3.19 8.00 6.70 3.41 3.55 3.27 2.66

Top Investors:

icici prudential pharma healthcare and diaganostics (p.h.d) fund

tata mutual fund - tata small cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Hikal - Quarterly Results
7th Aug 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback